Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.

M Fiegl; R Stauder; M Steurer; M Mian; Georg Hopfinger; Y Brychtova; C Skrabs; A Zabernigg; F Schmid; F Haslbaur; G Winder; A Walder; A Lang; D Voskova; Richard Greil; J Mayer; G Gastl

doi:10.1007/s00277-013-1966-z

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.

M Fiegl, R Stauder, M Steurer, M Mian, Georg Hopfinger (Co-author), Y Brychtova, C Skrabs, A Zabernigg, F Schmid, F Haslbaur, G Winder, A Walder, A Lang, D Voskova, Richard Greil (Co-author), J Mayer, G Gastl

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

15 Citations (Web of Science)

Original language	English
Pages (from-to)	26-77
Journal	ANNALS OF HEMATOLOGY
Volume	93
Issue number	2
DOIs	https://doi.org/10.1007/s00277-013-1966-z
Publication status	Published - 2014

Keywords

B-PROLYMPHOCYTIC LEUKEMIA
SUBCUTANEOUS ALEMTUZUMAB
RICHTER TRANSFORMATION
PROGNOSTIC-FACTORS
1ST-LINE THERAPY
PHASE-II
FLUDARABINE
CAMPATH-1H
RISK
TRANSPLANTATION

Access to Document

10.1007/s00277-013-1966-z

Cite this

Fiegl, M., Stauder, R., Steurer, M., Mian, M., Hopfinger, G., Brychtova, Y., Skrabs, C., Zabernigg, A., Schmid, F., Haslbaur, F., Winder, G., Walder, A., Lang, A., Voskova, D., Greil, R., Mayer, J., & Gastl, G. (2014). Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. ANNALS OF HEMATOLOGY , 93(2), 26-77. https://doi.org/10.1007/s00277-013-1966-z

Fiegl, M ; Stauder, R ; Steurer, M et al. / Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. In: ANNALS OF HEMATOLOGY 2014 ; Vol. 93, No. 2. pp. 26-77.

@article{c2a929cc963b47fc98a1698865315bf7,

title = "Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.",

keywords = "B-PROLYMPHOCYTIC LEUKEMIA, SUBCUTANEOUS ALEMTUZUMAB, RICHTER TRANSFORMATION, PROGNOSTIC-FACTORS, 1ST-LINE THERAPY, PHASE-II, FLUDARABINE, CAMPATH-1H, RISK, TRANSPLANTATION",

author = "M Fiegl and R Stauder and M Steurer and M Mian and Georg Hopfinger and Y Brychtova and C Skrabs and A Zabernigg and F Schmid and F Haslbaur and G Winder and A Walder and A Lang and D Voskova and Richard Greil and J Mayer and G Gastl",

note = "R. Greil Department of Internal Medicine III, Private Medical University of Salzburg, Salzburg, Austria",

year = "2014",

doi = "10.1007/s00277-013-1966-z",

language = "English",

volume = "93",

pages = "26--77",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

number = "2",

}

Fiegl, M, Stauder, R, Steurer, M, Mian, M, Hopfinger, G, Brychtova, Y, Skrabs, C, Zabernigg, A, Schmid, F, Haslbaur, F, Winder, G, Walder, A, Lang, A, Voskova, D, Greil, R, Mayer, J & Gastl, G 2014, 'Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.', ANNALS OF HEMATOLOGY , vol. 93, no. 2, pp. 26-77. https://doi.org/10.1007/s00277-013-1966-z

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. / Fiegl, M; Stauder, R; Steurer, M et al.
In: ANNALS OF HEMATOLOGY , Vol. 93, No. 2, 2014, p. 26-77.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.

AU - Fiegl, M

AU - Stauder, R

AU - Steurer, M

AU - Mian, M

AU - Hopfinger, Georg

AU - Brychtova, Y

AU - Skrabs, C

AU - Zabernigg, A

AU - Schmid, F

AU - Haslbaur, F

AU - Winder, G

AU - Walder, A

AU - Lang, A

AU - Voskova, D

AU - Greil, Richard

AU - Mayer, J

AU - Gastl, G

N1 - R. Greil Department of Internal Medicine III, Private Medical University of Salzburg, Salzburg, Austria

PY - 2014

Y1 - 2014

KW - B-PROLYMPHOCYTIC LEUKEMIA

KW - SUBCUTANEOUS ALEMTUZUMAB

KW - RICHTER TRANSFORMATION

KW - PROGNOSTIC-FACTORS

KW - 1ST-LINE THERAPY

KW - PHASE-II

KW - FLUDARABINE

KW - CAMPATH-1H

KW - RISK

KW - TRANSPLANTATION

U2 - 10.1007/s00277-013-1966-z

DO - 10.1007/s00277-013-1966-z

M3 - Original Article

C2 - 24292560

SN - 0939-5555

VL - 93

SP - 26

EP - 77

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

IS - 2

ER -

Fiegl M, Stauder R, Steurer M, Mian M, Hopfinger G, Brychtova Y et al. Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. ANNALS OF HEMATOLOGY . 2014;93(2):26-77. doi: 10.1007/s00277-013-1966-z